Sell:34.00pBuy:38.00pNo change
Beximco Pharmaceuticals Limited is a Bangladesh-based company, which manufactures pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company offers products in diverse therapeutic categories, which include antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, and dermatology. It offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable, and Large Volume Intravenous Fluids. The Company also offers render contract manufacturing services to other companies. Its brands include Napa, Napa Extra, Bizoran, Neofloxin, Atova, Azmasol, Arlin, Bexitrol F, D-Rise, Amdocal, Remmo, Tofen, and Tyclav. The Company’s subsidiaries include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), and Beximco Pharma API Limited (BPAL).
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.